Published in Anaerobe on May 11, 2016
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol (2010) 17.99
Multistate point-prevalence survey of health care-associated infections. N Engl J Med (2014) 8.78
Burden of Clostridium difficile infection in the United States. N Engl J Med (2015) 8.17
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature (2014) 5.51
Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques (2004) 4.72
Clostridium difficile infection. N Engl J Med (2015) 4.56
Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol (2004) 4.53
A mouse model of Clostridium difficile-associated disease. Gastroenterology (2008) 3.65
Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J Microbiol Methods (2010) 3.58
Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun (2009) 3.36
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev (2013) 2.58
Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect (2009) 2.33
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect (2008) 2.30
Weight gain after fecal microbiota transplantation. Open Forum Infect Dis (2015) 2.05
Comparative effectiveness of Clostridium difficile treatments: a systematic review. Ann Intern Med (2011) 1.98
Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J Bacteriol (2010) 1.82
Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol (2013) 1.79
Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease. J Infect Dis (2010) 1.62
Recovery of the gut microbiome following fecal microbiota transplantation. MBio (2014) 1.59
Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection. PLoS Pathog (2013) 1.55
Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infect Immun (2012) 1.43
Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls. MBio (2014) 1.40
Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection. Microbiome (2013) 1.26
Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins. Nat Med (2011) 1.19
Recurrent Clostridium difficile infection: From colonization to cure. Anaerobe (2015) 1.00
Pathway to Prevention of Nosocomial Clostridium difficile Infection. Clin Infect Dis (2015) 0.91
Prevention of Clostridium difficile Infection With Probiotics. Clin Infect Dis (2015) 0.90
Administration of kefir-fermented milk protects mice against Giardia intestinalis infection. J Med Microbiol (2013) 0.89
Safety characterization and antimicrobial properties of kefir-isolated Lactobacillus kefiri. Biomed Res Int (2014) 0.88
Staggered and tapered antibiotic withdrawal with administration of kefir for recurrent Clostridium difficile infection. Clin Infect Dis (2014) 0.86
Kefir improves fatty liver syndrome by inhibiting the lipogenesis pathway in leptin-deficient ob/ob knockout mice. Int J Obes (Lond) (2013) 0.85
Clostridium difficile infection: A brief update on emerging therapies. Am J Health Syst Pharm (2015) 0.85
Clostridium difficile Infection in Long-term Care Facilities: A Call to Action for Antimicrobial Stewardship. Clin Infect Dis (2015) 0.82
Protective effects of the fermented milk Kefir on X-ray irradiation-induced intestinal damage in B6C3F1 mice. Biol Pharm Bull (2012) 0.81
Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital. Curr Med Res Opin (2013) 0.80
Feces transplantation for recurrent Clostridium difficile infection: US experience and recommendations. Microb Ecol Health Dis (2015) 0.78
FDA slaps regs on fecal transplants. Increased steps for C. diff treatment draw mixed reactions from providers. Mod Healthc (2013) 0.78
Resolution of recurrent Clostridium difficile-associated diarrhea using staggered antibiotic withdrawal and kefir. Minn Med (2009) 0.77
Composition and function of the undernourished neonatal mouse intestinal microbiome. J Nutr Biochem (2015) 0.80
Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection. Anaerobe (2016) 0.79
Probiotics as adjunctive therapy for preventing Clostridium difficile infection - What are we waiting for? Anaerobe (2016) 0.77